about
Proteomic-Based Approaches for the Study of Cytokines in Lung CancerTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsMiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer.PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage.Identification of proteomic signatures associated with lung cancer and COPD.MicroRNA-dependent regulation of transcription in non-small cell lung cancer.Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer.Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies.Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy.Proteomic biomarkers in lung cancer.Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.Current Challenges in Cancer Treatment.Biological therapies in nonsmall cell lung cancer.Immunovirologic characteristics of human immunodeficiency virus-infected patients consisting mainly of injecting drug users on highly active antiretroviral treatment with prolonged virologic failure.HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse.Analysis of quasispecies in the viral 5' untranslated region of hepatitis C virus to evaluate ribavirin mutagenic effect in patients receiving ribavirin and interferon-alfa.Prevalence and factors involved in discordant responses to highly active antiretroviral treatment in a closely followed cohort of treatment-naïve HIV-infected patients.HIV-hepatitis C virus co-infection is associated with decreased plasmatic IL-7 levels.Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.Effect of hepatitis C virus coinfection on humoral immune alterations in naïve HIV-infected adults on HAART: a three year follow-up study.Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma.The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD.VeriStrat: a prognostic and/or predictive biomarker for advanced lung cancer patients?IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).Thymic volume predicts CD4 T-cell decline in HIV-infected adults under prolonged treatment interruption.Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer.Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulationLong non-coding RNAs as monitoring tools and therapeutic targets in breast cancerMAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinomaThymic Function-Related Markers Within the Thymus and Peripheral Blood: Are They Comparable?Corrigendum to "Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications"Corrigendum to "Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer"FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved EfficacyFGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effectiveA patent review of FGFR4 selective inhibition in cancer (2007-2018)
P50
Q26738539-7E96B26E-E931-48E3-ACA4-187B2C93BCF7Q26741318-7B4BB445-167D-4D20-B136-C1A9F2FBF8B0Q34203585-21D83CDB-5B2B-458B-ADEE-9647C4552E90Q34475004-5BF64C12-BAC3-4A33-902B-8A3F5A8ADCEAQ34579409-2BFF748A-11DB-43EE-8961-42A22175EF4FQ34715428-CBA01C52-9F77-4FA5-B557-D4E66CFA21FDQ35119983-A7C15BA5-0B00-4883-AD29-3FD593B9BC4EQ35742491-5294A29C-ABB8-40D9-930C-379D7FD4013CQ37305920-3323E832-ED25-47A2-A0AB-B63733C69FE2Q37619675-6A3643D9-9990-421F-B858-0A210807608DQ37665411-78B67587-44D3-45BE-97D1-42608647CE49Q38100750-82215ED2-BAB1-46E5-83C9-A9E24565CBDEQ38742644-A7E0650F-B1D6-46C8-BC0A-605FA7A98CC9Q38829296-9FC325EA-021A-44BC-AF98-8697DDA42AF4Q39158798-1A8271B1-5DF7-47D9-9CF6-D1AF1EFB3BC3Q39546620-C25F1C97-D75B-415E-B090-E2F524741945Q42981248-D6B7E356-8068-4BF4-B377-0C8BD8AC25D0Q42989461-6623C16C-4F71-464C-AC96-FD185D089260Q44353862-372F7635-1E67-44D4-9010-E170B2F8B432Q44437564-CDE16E51-4A6C-461B-8028-2BCF7C18380DQ44627811-D33991E3-19D3-4BE7-986A-0342B5210262Q45442100-27307114-5031-4BE6-A167-05898CDF6A99Q47100472-2D7C03B4-9A43-4D65-9494-C80222F07E17Q47101376-AF58158E-ECDC-4A2D-927F-7E0A7EABE663Q49306280-A5EBEAE9-99C5-4FE3-A0BE-FEF18AAF84F4Q50943403-6A33E958-7DF6-4772-AF70-BDCE2C6ABE13Q51093311-E1237188-C1B3-474A-B6F4-48A9040C305DQ51136000-682B392F-19E6-4FEF-BB72-2B8C0F114881Q51571804-0A228ECA-A690-4AB1-A5F0-1D780F0D36C0Q51940333-873677D3-8E66-4713-982B-AB2812B80EBFQ55105956-FC1B6B29-402B-4674-997E-B6F7C732FA9FQ57080005-2715897E-D8A4-4DAF-B1BF-9149BC69D9A3Q58553890-0B9EC90A-EFDA-46EB-8BF5-6BDEC35E9CE3Q58770545-02FDA136-BFA8-40E5-BD81-3121E7370BDCQ58860912-F44C8FDB-3056-4FE2-9A58-2758A4CCA02CQ62718435-D4D04BC6-A085-4E48-91D0-E45FA9D4513EQ62718442-029F8635-AF7E-4E5A-B5C8-AFDD40BA73A4Q63982500-85ACADBB-95BC-4AA2-89FE-9E87CC8D0482Q63982502-FFA74351-7B16-4BAE-98A3-36F459ED83EDQ92410967-6FB6478C-7DA5-4A8B-A2AA-5CF3D94F553B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sonia Molina-Pinelo
@ast
Sonia Molina-Pinelo
@en
Sonia Molina-Pinelo
@es
Sonia Molina-Pinelo
@nl
Sonia Molina-Pinelo
@sl
type
label
Sonia Molina-Pinelo
@ast
Sonia Molina-Pinelo
@en
Sonia Molina-Pinelo
@es
Sonia Molina-Pinelo
@nl
Sonia Molina-Pinelo
@sl
prefLabel
Sonia Molina-Pinelo
@ast
Sonia Molina-Pinelo
@en
Sonia Molina-Pinelo
@es
Sonia Molina-Pinelo
@nl
Sonia Molina-Pinelo
@sl
P1053
M-4643-2015
P106
P21
P31
P3829
P496
0000-0002-5726-2453